Exclusive

Publication

Byline

"TB diagnostics is moving from detection alone to comprehensive, timely and reliable insights that can guide treatment"

India, Nov. 1 -- India experiences a wide range of infectious diseases influenced by geography, climate, and population density. What are the current challenges facing the diagnostics market for infec... Read More


India 2030: Who Supplies the Next 10 Million?

India, Nov. 1 -- image credit- shutterstock The battle for India's diabetes market is no longer simply about who sells the most insulin. It is about who can reach more patients, make treatment afford... Read More


Can India accelerate ocular healthcare with AI?

India, Nov. 1 -- image credit- freepik As per reports, glaucoma has emerged as a major public health challenge in India, currently affecting over 12 million people, most of whom remain undiagnosed. B... Read More


India's Neurotech Startups Take Brain Science from Lab to Market

India, Nov. 1 -- image credit- freepik For decades, neuroscience in India largely remained within hospitals, universities and research laboratories. The brain was difficult to measure, harder to trea... Read More


Beyond the Spin: Can Indian Centrifuge Makers Move Up the Technology Curve?

India, Nov. 1 -- image credit- freepik A centrifuge is among the most familiar instruments in a laboratory, but the business of centrifugation is becoming increasingly sophisticated. Pharmaceutical c... Read More


"A key priority is to look beyond the cost of medicines and strengthen the entire oncology-care pathway, particularly screening, early diagnosis and timely treatment"

India, Nov. 1 -- Will the 30 per cent trade-margin cap materially improve cancer-care affordability, and what could limit its impact? The NPPA's decision to cap trade margins at 30 per cent for 137 a... Read More


"The biggest challenges in sourcing synthetic DNA are turnaround time, customisation, logistics and supply reliability"

India, Nov. 1 -- What prompted you to partner with DNA Script, and what market opportunity do you see for on-demand DNA synthesis in India? Imperial Life Sciences saw a strong opportunity because Ind... Read More


Beyond Centralised vs Distributed: India's Emerging MRD Model

India, Nov. 1 -- The minimal residual disease (MRD) testing market, one of the fastest-growing segments of the global diagnostics industry, has reached an inflection point. The defining question is no... Read More


Land values around Government City set to rise

DODOMA, Nov. 1 -- LAND values in areas surrounding Mtumba Government City are expected to appreciate as the new administrative hub attracts more residents, businesses and investment, raising expectati... Read More


IMF Diagnostic exposes deep-seated vulnerabilities in Sri Lanka's revenue administration

Sri Lanka, Nov. 1 -- Sri Lanka's post-crisis fiscal recovery-which saw tax revenues rebound from 7.3% of GDP in 2021 to 15.4% in 2025-faces serious institutional headwinds. A comprehensive Revenue Ad... Read More